Connect with us

Top Stories

The UN warns millions will die by 2029 if US funding for HIV programs isn’t replaced

Published

on


LONDON (AP) — Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades and provided life-saving medicines for some of the world’s most vulnerable.

But in the last six months, the sudden withdrawal of U.S. money has caused a “systemic shock,” U.N. officials warned, adding that if the funding isn’t replaced, it could lead to more than 4 million AIDS-related deaths and 6 million more HIV infections by 2029.

A new UNAIDS report released Thursday said the funding losses have “already destabilized supply chains, led to the closure of health facilities, left thousands of health clinics without staff, set back prevention programs, disrupted HIV testing efforts and forced many community organizations to reduce or halt their HIV activities.”

It also said that it feared other major donors scaled back their support, reversing decades of progress against AIDS worldwide — and that the strong multilateral cooperation is in jeopardy because of wars, geopolitical shifts and climate change.

A ‘lifeline’ removed

The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January, when U.S. President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the U.S. AID agency.

Andrew Hill, an HIV expert at the University of Liverpool who is not connected to the United Nations, said that while Trump is entitled to spend U.S. money as he sees fit, “any responsible government would have given advance warning so countries could plan,” instead of stranding patients in Africa where clinics were closed overnight.

The U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, was launched in 2003 by U.S. President George W. Bush, the biggest-ever commitment by any country focused on a single disease.

UNAIDS called the program a “lifeline” for countries with high HIV rates, and said that it supported testing for 84.1 million people, treatment for 20.6 million, among other initiatives. According to data from Nigeria, PEPFAR also funded 99.9% of the country’s budget for medicines taken to prevent HIV.

U.N. Assistant Secretary-General Angeli Achrekar, a UNAIDS deputy executive director who was PEPFAR’s principal deputy coordinator until January 2023, said the program is under review by the Trump administration though Secretary of State Marco Rubio issued a waiver “to continue life-saving treatment.”

““The extent to which it will continue in the future, we don’t know,” she told a video news conference with U.N. reporters in New York. “We are cautiously hopeful that PEPFAR will continue to support both prevention and treatment services.”

A gap impossible to fill

In 2024, there were about 630,000 AIDS-related deaths worldwide, per a UNAIDS estimate — the figure has remained about the same since 2022 after peaking at about 2 million deaths in 2004.

Even before the U.S. funding cuts, progress against curbing HIV was uneven. UNAIDS said that half of all new infections are in sub-Saharan Africa.

Tom Ellman of Doctors Without Borders said that while some poorer countries were now moving to fund more of their own HIV programs, it would be impossible to fill the gap left by the U.S.

“There’s nothing we can do that will protect these countries from the sudden, vicious withdrawal of support from the U.S.,” said Ellman, head of the group’s South Africa medical unit.

Experts also fear another significant loss — data.

The U.S. paid for most HIV surveillance in African countries, including hospital, patient and electronic records, all of which has now abruptly ceased, according to Dr. Chris Beyrer, director of the Global Health Institute at Duke University.

“Without reliable data about how HIV is spreading, it will be incredibly hard to stop it,” he said.

A new drug revives hope

The uncertainty comes in the wake of a twice-yearly injectable that many hope could end HIV. Studies published last year showed that the drug from pharmaceutical maker Gilead was 100% effective in preventing the virus.

At a launch event Thursday, South Africa’s health minister Aaron Motsoaledi said the country would “move mountains and rivers to make sure every adolescent girl who needs it will get it,” saying that the continent’s past dependence upon US aid was “scary.”

Last month, the U.S. Food and Drug Administration approved the drug, called Yeztugo, a move that should have been a “threshold moment” for stopping the AIDS epidemic, said Peter Maybarduk of the advocacy group Public Citizen.

But activists like Maybarduk said Gilead’s pricing will put it out of reach of many countries that need it. Gilead has agreed to sell generic versions of the drug in 120 poor countries with high HIV rates but has excluded nearly all of Latin America, where rates are far lower but increasing.

“We could be ending AIDS,” Maybarduk said. “Instead, the U.S. is abandoning the fight.”

___

Associated Press writer Edith M. Lederer at the United Nations contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.

___

A previous version of this story was corrected to show that the name of the drug is Yeztugo, not Sunlenca.





Source link

Top Stories

Why plastic-filled ‘Neptune balls’ are washing up on beaches

Published

on


In 2018 and 2019, Sanchez-Vidal’s team examined seagrass balls washed up on four beaches on the island of Mallorca, Spain. On the shores of Sa Marina, Son Serra de Marina, Costa dels Pins and Es Peregons Petits, they found plastic debris in half of the loose seagrass leaf samples, up to 600 fragments per kilogram (2.2lb) of leaves.

Only 17% of Neptune balls contained plastic, but where it was found it was densely packed – nearly 1,500 pieces per kilogram. Tighter bundled balls were more effective at trapping plastic.

“After our paper was published, a lot of people started sending me [pictures of] monster Neptune balls,” says Sanchez-Vidal. These are balls that capture larger and more visible pieces of plastic.

“Sometimes they had sanitary towels, tampons, wet wipes – things with a lot of cellulose, so they sink,” she explains: “No, I didn’t really want to receive those pictures from everybody,” she jokes.

Getty Images Neptune balls are natural products of Posidonia seagrass meadows, but the plastic inside some of them comes from human pollution (Credit: Getty Images)Getty Images
Neptune balls are natural products of Posidonia seagrass meadows, but the plastic inside some of them comes from human pollution (Credit: Getty Images)



Source link

Continue Reading

Top Stories

A shutdown fight and Epstein drama await as Congress returns to Washington

Published

on


WASHINGTON — A government shutdown deadline, a standoff over President Donald Trump’s nominees and a renewed clash over the Jeffrey Epstein files await Congress as it returns Tuesday after a month-long August recess.

The top item on the agenda is the government funding deadline of Sept. 30 to avoid a shutdown. An unusual Republican and Democratic pairing says they believe they’ll have the support they need to force a House vote requiring the Justice Department to release the Epstein files. And Republicans are hatching plans to change Senate rules to speed up confirmation of Trump’s personnel, amid drama over the firing and exodus of top public health officials from the Trump administration.

Shutdown deadline is Sept. 30

The battle over federal funding has intensified in recent days in anticipation of lawmakers’ return to town, with any bill requiring 60 votes, and thus bipartisan support, to pass the Senate.

There’s no framework or “top line” agreement on how much to spend, let alone how to allocate that funding. And with just weeks to go, the division is growing rather than narrowing.

The White House notified lawmakers Friday that it plans to bypass them and slash $4.9 billion in federal funds using a “pocket rescission,” a tactic that the top congressional watchdog calls “illegal.”

The move drew condemnation from Democrats and a top Republican.

Senate Minority Leader Chuck Schumer, D-N.Y., called it “unlawful” and said it is “further proof President Trump and Congressional Republicans are hellbent on rejecting bipartisanship and ‘going it alone’ this fall.”

“As the country stares down next month’s government funding deadline on September 30th, it is clear neither President Trump nor Congressional Republicans have any plan to avoid a painful and entirely unnecessary shutdown,” Schumer said.

Senate Appropriations Chair Susan Collins, R-Maine, said: “Any effort to rescind appropriated funds without congressional approval is a clear violation of the law.”

Collins has issued similar warnings in the past, which have been ignored by the White House and GOP leaders, who embraced Trump’s previous round of “rescissions” to undo funding approved by Congress.

Hard-right Republicans are also demanding to keep spending low.

“Spending has got to stay flat or go down. I mean, that’s the deal,” said Rep. Chip Roy, R-Texas. “Whatever format that takes … but it needs to stay flat or go down.”

Pressure builds on Epstein files

In July, Rep. Thomas Massie, R-Ky., a conservative Trump antagonist, rolled out a resolution to force the Justice Department to release the Epstein files, predicting pressure would build throughout the August recess and reach a boiling point by the time Congress returns this week.

But Massie and his Democratic co-author of the legislation, Rep. Ro Khanna of California, are leaving nothing to chance. On Wednesday, they plan to host a Capitol news conference featuring sexual abuse survivors of Epstein, the convicted sex offender who took his own life in 2019, and his associate, Ghislaine Maxwell, who is serving a 20-year prison sentence for her role in recruiting and trafficking minors for sex.

Khanna said he believes they’ll have the requisite 218 member signatures needed for their discharge petition — a process that would circumvent GOP leadership and force a floor vote to release the files.

“The testimonials from Epstein’s victims are going to be explosive on Sept. 3, and I am confident all 212 Democrats will sign it and we will have more than six Republicans sign,” Khanna told NBC News.

Speaker Mike Johnson, R-La., has opposed the discharge push. During an appearance on CNN, he called it a “moot point” and “not necessary” because the House Oversight Committee already has been reviewing a tranche of documents provided by the Justice Department.

But Massie and Khanna say the Trump administration is not moving fast enough. The Oversight panel subpoenaed the DOJ for its investigative files in the Epstein case, which total roughly 100,000 pages. The panel said it received about a third of those documents last Friday and that more would be turned over in the future.

The Oversight Committee has been conducting interviews with high-profile former government officials as part of its probe into Epstein. Former Labor Secretary Alex Acosta, a former federal prosecutor in Florida whose office reached a non-prosecution deal with Epstein in 2008, will appear voluntarily before the panel on Sept. 19.

Will a stock trading ban be successful?

Lawmakers often do not police themselves. But as they return to Washington, there will be a renewed and highly public bipartisan push to ban them from owning and trading individual stocks amid concerns over potential conflicts of interest.

Rep. Anna Paulina Luna, R-Fla., is vowing to file a discharge petition to force a vote on a bill by Rep. Tim Burchett, R-Tenn., to ban congressional stock trading.

“Insider trading, individual stock trades by members of Congress — they’re crooked as a dog’s leg. Everybody knows it,” Burchett said. “It’s going to be hated and loved in both parties.”

And members of both parties have been signing onto the Ending Trading and Holdings in Congressional Stocks or ETHICS Act, legislation authored by Rep. Raja Krishnamoorthi, D-Ill. The bill would bar lawmakers, their spouses and their dependent children from owning or trading individual stocks, securities, commodities or futures.

Among those who have co-sponsored the bill are GOP Reps. Michael Cloud of Texas, Jen Kiggans of Virginia, and Mike Lawler of New York, and Democratic Reps. Joe Neguse of Colorado, Josh Riley of New York and Khanna.

“Members of Congress should serve the public, not pad their stock portfolios,” said Krishnamoorthi, who is running for the Senate. “A stock trading ban is just common sense — it’s about restoring trust, preventing conflicts of interest, and making sure lawmakers put constituents ahead of their own bottom line.”

Before the summer recess, Republican Sen. Josh Hawley of Missouri, a potential 2028 presidential contender, teamed with Democrats to pass a stock ban for politicians through the Homeland Security Committee, sparking anger from Trump and Hawley’s own Senate GOP colleagues. Majority Leader John Thune, R-S.D., said he would not put the bill, which would prohibit owning or trading stocks for future presidents, vice presidents and lawmakers, on the Senate floor for a vote.

With so many lawmakers owning stocks, it would be an uphill battle to move such a ban through both chambers.

Senate eyes a ‘nuclear’ move and CDC fallout

Meanwhile, Republicans are gearing up to change the rules of the Senate using the so-called “nuclear option” in order to push Trump’s nominees for sub-Cabinet positions through faster.

They blame it on Democratic obstruction in granting speedy votes for Trump’s personnel, saying it has reached new heights as even nominees that have bipartisan support are being slowed down.

“Senate Republicans are determined to confirm Mr. Trump’s qualified nominees one way or another. Republicans are considering changes to the Senate rules to end the most egregious delay tactics,” Senate Majority Whip John Barrasso, R-Wyo, wrote in a recent opinion piece under the headline, “Chuck Schumer’s Unprecedented Blockade.”

Schumer responded on X, “Historically bad nominees deserve a historic level of scrutiny by Senate Democrats.”

He alluded to recent Trump nominees whom he fired just weeks or months into the job. That includes CDC Director Susan Monarez and IRS Commissioner Billy Long, who were fired in August after getting confirmed by the Senate in July and June, respectively.

“No matter how fast Trump hires and fires them,” Schumer wrote last week, “Senator Barrasso is always at the ready to rubber-stamp the next one!”

The Monarez firing has drawn additional scrutiny on Health and Human Services Secretary Robert F. Kennedy, Jr., who triggered her removal and the resignations of top health officials who say the administration was manipulating data in unscientific ways to advance a political agenda.

As Democrats demand hearings into what they call Kennedy’s anti-vaccine crusade, Sen. Bill Cassidy, R-La., the chair of the health committee, has promised “oversight” without getting specific. Cassidy provided a pivotal vote to getting Kennedy through committee and confirmed in the Senate.

“We need to know what the data says and where it is coming from, so the CDC and HHS can make the best decisions,” Cassidy wrote on X, saying his goals align with Trump.

Cassidy, a doctor, has also feuded in recent days about the efficacy of vaccines with Sen. Rand Paul, R-Ky., a committee member more aligned with Kennedy on the matter.



Source link

Continue Reading

Top Stories

Congress returns to a messy fall with Democrats ready to fight

Published

on


Congress is bracing for a politically bruising fall as lawmakers return to Washington on Tuesday, with massive fights upcoming on government funding, the Jeffrey Epstein files and President Donald Trump’s policing push.

After a summer of simmering tensions on Trump’s nationwide deportations, National Guard deployment in Washington, DC, and a string of high-profile firings, Democrats are ready to fight back.

And the minority party won’t have to wait long for its opportunity to spar with Trump. Republicans and Democrats are already entering a high-stakes funding standoff ahead of a September 30 funding deadline, which marks Congress’ first bout of bipartisan dealmaking in months. Already, Democrats are signaling they want new checks on Trump’s power and a rollback of the president’s signature domestic policy law, but White House officials say they’re in no mood to yield to those demands and expect Democrats to help keep the government open.

Before Congress hits that end of September deadline, though, Speaker Mike Johnson and Senate Majority Leader John Thune will be navigating plenty of other partisan battles.

On the House side, that includes a floor fight over the Jeffrey Epstein files that is likely to rankle House Republicans right as lawmakers return this week.

GOP Rep. Thomas Massie of Kentucky and his Democratic counterpart, Rep. Ro Khanna of California, will begin collecting signatures this week for a closely watched bill that would require the Trump administration to turn over all relevant Epstein case material. And because they’re using a tactic to circumvent party leaders known as a discharge petition, all they need is 218 signatures to force that bill to the floor – creating a political headache for Johnson.

Speaking to CNN on Friday, Johnson called the Massie-Khanna effort “moot,” but he acknowledged “there may be a floor vote of one measure or another,” suggesting without offering details that there could be a separate, leadership-backed resolution that could come to the floor.

On the Senate side, Republicans will be forced to wade into the chaos at the Centers for Disease Control, where Trump fired an official that the Senate confirmed just days before leaving for its August recess. Senators will also be pressed on the escalating drama at the Federal Reserve – which has long been seen as above politics – where ousted Federal Reserve Governor Lisa Cook is now suing Trump for firing her.

At the same time, Senate GOP leaders will continue to face pressure to change their chamber’s longstanding rules to speed up the confirmation process for Trump nominees, while some senators are likely to make the case to allow the president to make recess appointments – a further extension of his presidential power.

Trump has also personally added more items to Congress’ to-do list in September. He declared last week that he was working with Johnson and Thune on a major crime package that will further stoke partisan battles.

Johnson told CNN on Friday that Republicans would first address crime in Washington, then look to other cities in America, with a focus on addressing what he called a “juvenile crime wave.” And relatedly, Congress will face a vote in mid-September to extend Trump’s authority to bring the National Guard in to assist with DC policing, which faces steep odds in the Senate, where it will need 60 votes.

“It’s gonna be a sh*tty fall,” one House member said, summing up the fights over government spending, the Epstein files and Trump’s policing push.

Democrats were already preparing for a brawl with Trump over this September’s funding deadline. Then came the White House’s decision to cancel nearly $5 billion in foreign aid funding – subverting Congress’ power of the purse in an untested maneuver that will surely be challenged in courts.

Top Democrats’ resolve to fight Trump only strengthened after the White House’s move, with Jeffries calling it a “brazenly unlawful scam” to undermine Congress and describing Trump as a “wannabe king.”

The White House, however, is downplaying Democrats’ threats and insisting that they will ultimately agree to keep the government open without securing any concessions from Trump.

“It’s very hard for me to believe that they are going to oppose a clean (continuing resolution) that would cause them to be responsible for a government shutdown,” a White House official said.

Massie and Khanna, the House duo that has loudly beat the drum on Epstein transparency, will hold a press conference on September 3 that will feature people who say they were victims of the late financier and sex offender’s sex trafficking ring.

“This press conference is going to be explosive. It’s the first time that a lot of these victims are speaking out publicly,” Khanna told CNN on Friday.

The two will be working to collect the 218 signatures needed on their discharge petition to trigger a full vote on the floor, bypassing GOP leaders who do not want to hold the vote. Both Khanna and Massie have said publicly they believe all Democrats will sign on and that they will get the necessary six Republicans to reach 218.

“I’m confident we’ll get 212 Democrats to sign this by the end of the week,” Khanna told CNN, adding that he’s working with Jeffries.

But it’s not clear how many Republicans will be willing to sign on. Rep. Jeff Van Drew, a New Jersey Republican who is a cosponsor of the Massie-Khanna bill, told CNN he was not willing to sign onto the discharge petition.

“I think it has lost a little bit of momentum,” Van Drew told CNN when asked about the Epstein transparency push, adding: “I support releasing whatever we can but not forcing by discharge.”

Massie said earlier this month that he hopes the press conference – and the fact that many victims will be addressing the public for the first time – will help convince more members of the GOP conference to vote to release the files.

“You’re virtually implicating yourself or your donors or some of your friends, if you vote against this,” Massie in an interview with anti-vaccine group Children’s Health Defense that was posted on its website in August.

The House Oversight panel this month received a spate of documents from the Department of Justice on the Epstein matter but Democrats said it contained little new information. The panel has demanded more documents from the Epstein estate that are expected to come by September 8, as well, but Khanna said he believes lawmakers aren’t willing to wait for that deadline.

Oversight Committee Chair James Comer has said the panel plans to meet with Epstein victims and their attorneys on Tuesday, as they work through “complicated” issues around making more information public.

Lawmakers who exercise oversight of key administration positions will return to grapple with recent dramatic shakeups, including Trump’s push to fire Cook and the ousting of newly installed CDC Director Dr. Susan Monarez.

Democrats erupted in outrage after Trump said he fired Cook, drawing questions about the constitutionality of the move that could open a new legal battle over executive authority.

Sen. Elizabeth Warren, the top Democrat on the Senate Banking Committee, called it an “authoritarian power grab that blatantly violates the Federal Reserve Act,” adding that “any court that follows the law will overturn it.”

Warren and other Democrats in the committee have asked the chair, Sen. Tim Scott, to postpone Thursday’s planned confirmation hearing for Federal Reserve board nominee Stephen Miran as the legal drama over Cook’s firing plays out.

Republicans have remained mostly mum on the issue, but GOP Sen. Todd Young acknowledged the unprecedented nature of the move when pressed by reporters on Capitol Hill.

“It’s breaking new ground, but I don’t know whether the law allows it or not. I haven’t studied that law,” he said.

Senators of both parties will likely ratchet up pressure on Health and Human Services Secretary Robert F. Kennedy Jr. after Monarez and other top CDC officials left the agency amid clashes with the administration over vaccine safety.

GOP Sen. Bill Cassidy, a medical doctor who chairs the Senate Health, Education, Labor and Pensions Committee, said the departures would “require oversight” from his panel.

Cassidy cast the pivotal vote to confirm Kennedy earlier this year after he said he received assurances that Kennedy would not dismantle federal support for vaccines.

Sen. Bernie Sanders, the ranking member on the Senate HELP panel, echoed Cassidy’s call for accountability, demanding that Kennedy and Monarez testify to the committee “as soon as possible.”

Kennedy is also expected to testify before the Senate Finance Committee on Thursday about Trump’s health care agenda.

A Ukrainian service member fires a self-propelled howitzer towards Russian troops near a front line in Ukraine's Zaporizhzhia region, on August 20.

As Washington awaits a potential high-stakes meeting between Russian President Vladimir Putin and Ukrainian President Volodymyr Zelensky, Congress could decide on its own to ratchet up pressure on the Trump administration to help end the war.

GOP Sen. Lindsey Graham, who led the bipartisan Russia sanctions legislation that ultimately did not make it to the Senate floor this summer, implored Trump to be “tough,” urging him to implement further sanctions on countries that buy oil and gas from the Kremlin.

He said in an interview on Fox that he intends to push Senate leaders to bring up his bill, cosponsored last year by Democratic Sen. Richard Blumenthal, that would designate Russia as a state sponsor of terrorism and make the country “radioactive” until they return the 19,000 children taken from Ukraine.

Graham also encouraged Trump to implement further tariffs on China to “take it to the next level,” arguing that Chinese President Xi Jinping could convince Putin to end the war.

Though Graham had previously lobbied Trump to come out in support of his sanctions bill, he and other GOP lawmakers backed away from demanding a vote before the August recess when Trump threatened to sanction Russia if Putin didn’t end the war quickly, though it is now unclear if or when that will happen.

Pressed on whether he has a sense of a timeline for any of the secondary sanctions he’s encouraging, Graham said it was up to Trump, and that he “trust(s) his judgment.”

Thune, who had floated the idea of bringing Graham’s bill to the floor before recess, vowed to provide Trump with “any economic leverage needed” over Russia as the president met with Zelensky and other European leaders.

Thune’s counterpart, Johnson, told CNN he’s “satisfied” with Trump’s efforts on Russia-Ukraine and thinks they’re “moving in the right direction.” Asked whether Congress should pass sanctions, Johnson said “it may come to that and (he’s) in favor of that.”





Source link

Continue Reading

Trending